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Copyright © 2009 JCBN Summary Ubiquinol-10 (QH2), the reduced form of Coenzyme Q10 (CoQ10) serves as a potent
antioxidant of lipid membranes. Because many antioxidants reveal potent anti-inflammatory
effects, the influence of QH2 on lipopolysaccharide (LPS)-induced pro-inflammatory cytokines
and chemokines were determined in the human monocytic cell line THP-1. Stimulation of cells
with LPS resulted in a distinct release of Tumour necrosis factor-alpha (TNF-α), Macrophage
inflammatory protein-1 alpha (MIP-1α), Regulated upon activation, normal T cell expressed
and secreted (RANTES) and Monocyte chemotattractant protein-1 (MCP-1). The LPS-induced
responses were significantly decreased by pre-incubation of cells with QH2 to 60.27 ± 9.3%
(p = 0.0009), 48.13 ± 6.93% (p = 0.0007) and 74.36 ± 7.25% (p = 0.008) for TNF-α, MIP-1α and
RANTES, respectively. In conclusion, our results indicate anti-inflammatory effects of the
reduced form of CoQ10 on various proinflammatory cytokines and chemokines in vitro.
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Introduction
Exposure of cells to the pro-inflammatory lipopoly-
saccharide (LPS) triggers TLR4-dependent phosphorylation
cascades which lead to activation of NFκB. This central
transcription factor induces the expression and subsequent
secretion of various pro-inflammatory cytokines and
chemokines [1–3]. Reactive oxygen species (ROS) are
important for the activity of the TLR4-signalling pathway
[4]. Accordingly, antioxidants are described as anti-
inflammatory agents [5, 6]. Because Coenzyme Q10 (CoQ10)
is a potent antioxidant, we postulated that this molecule
possesses anti-inflammatory properties. More recently was
shown that CoQ10 supplementation minimizes oxidative
stress during statin drug therapy [7]. Indeed, we found a
reduction of LPS-induced cytokine release by CoQ10 in
murine and human monocytic cell lines [8]. In the latter
study, we treated cells with the oxidized form of CoQ10
(ubiquinone-10) which is converted intracellular to
ubiquinol-10 (QH2). As only the reduced form of CoQ10 can
act as an antioxidant, here we studied effects on secretion of
the cytokine TNF-α and different chemokines in LPS-
stimulated THP-1 cells that were directly incubated with QH2.
Material and Methods
Reagents
Lipopolysaccharide (LPS, E.coli O55:B5) was obtained
from Sigma-Aldrich (Taufkirchen, Germany). The aqueous
solutions of ubiquinol-10 (PEG-60 hydrogenated castor oil,
ubiquinol-10, glycerol, water) and the corresponding
vehicle (no ubiquinol-10 supplement) were received from
KANEKA Corporation (Osaka, Japan).Reduced Form of Coenzyme Q10 and Inflammation
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Cell culture
Cultivation of THP-1 cells occurred routinely in RPMI
medium 1640 supplemented with 10% FCS and 1% anti-
biotics (penicillin/streptomycin) in a humidified incubator
containing 5% CO2 at 37°C. For determination of TNF-α
and chemokines, cells were plated at a density of 0.5 × 106
cells in a 12-well plate for 24 h before pre-incubation.
Subsequently, cells were preincubated with either 10 μM
ubiquinol-10 or the reference substances pyrrolidine-
dithiocarbamate (PDTC) or N-acetyl-cysteine (NAC), or the
respective vehicle control. After 24 h, cell culture medium
was removed and fresh LPS-containing medium (1 μg/ ml)
was added for 4 h. Finally, for cytokine determination via
ELISA, supernatants were kept and stored at −80°C. For
protein determination via the BRADFORD method, cells
were collected into NET-buffer.
Cytotoxicity
For determination of cell viability, the Cell-Titer Glo®
Luminescent Assay was used. Thus, total ATP levels were
measured as an index of the viable cell number. The
luminescence was detected on a GloMax® (Promega,
Mannheim, Germany).
Determination of TNF-α and chemokines
Using TNF-α as an internal control, this cytokine was
determined by DuoSet ELISA (R&D Systems, Wiesbaden,
Germany) as well as multiplex suspension array technology
(BioRad, Munich, Germany) according to the manufacturer’s
instructions. The chemokines MCP-1, MIP-1α and RANTES
were determined by the multiplex suspension array system.
Protein concentration
Cells were collected into NET-buffer (50 mM TRIS
[pH 7.5], 150 mM NaCl, 1 mM EDTA [pH 8.0], 0.5%
NP-40) and the cell suspension was treated with ultrasonics
and then centrifugated by 14000 rpm at 4°C for 20 min.
Determination of protein concentration occurred in the
resulting supernatant by the Bradford method according to
the manufacturer’s instructions.
Statistics
All data are results of two (PDTC, NAC) or three (QH2)
independent biological experiments performed in duplicate
and expressed as means ± standard error of the mean (SEM).
Results were analyzed by an unpaired two-sided Student’s
t-test using SPSS 11.5 for Windows and GraphPad Prism 4.0
software. p-values less than or equal to 0.05 were considered
statistically significant.
Results and Discussion
NFκB is a multisubunit transcription factor that is ubiqui-
tously expressed in different cell types and can be activated
by several agents such as LPS, TNF-α or the oxidant
hydrogen peroxide (H2O2) [9]. This activation process
includes phosphorylation of the IκB subunit and its
dissociation from the inactive cytoplasmic complex. Thus,
the active dimer of p50 and p65 translocates into the nucleus
where specific target genes of pro-inflammatory mediators
and cytokines become immediately up-regulated [9,  10].
However, this NFκB-activating cascade was shown to be
inhibited by antioxidants such as PDTC and NAC. This
has led to the hypothesis that oxygen radicals are key players
in the activation of NFκB through an redox-dependent
mechanism [9, 11, 12]. Because many antioxidants reveal
potent anti-inflammatory effects, the influence of QH2 on
LPS-induced pro-inflammatory cytokines and chemokines
was determined in the human monocytic cell line THP-1. All
experiments were performed with the well known radical
scavengers PDTC and NAC to validate the putative anti-
inflammatory effects of QH2. To implement culture condi-
tions that do not lead to unspecific side effects, cell vitality
was measured at different medium concentrations of QH2.
As shown in Table 1, no cytotoxic effects were found for
PDTC (100 μM), NAC (100 μM) and QH2 (1, 10, 100 μM).
For further experiments we used 10 μM QH2, because this
concentration leads to a significantly higher intracellular
QH2 content in THP-1 cells and is also achievable in human
serum through QH2 supplementation (unpublished results).
As shown in Figure 1A-D, unstimulated THP-1 monocytes
secrete low amounts of the pro-inflammatory cytokine TNF-
α and chemokines MIP-1α, RANTES and MCP-1 into the
medium. However, stimulation with LPS induces approxi-
mately 58-(TNF-α), 7-(MIP-1α), 2-(RANTES) and 4-
(MCP-1) fold higher levels of these pro-inflammatory
Table 1. Effect of ubiquinol-10 (QH2) and the reference substances PDTC and NAC on viability of THP-1 cells.
THP-1 cells were either treated with 1–100 μM QH2 or 100 μM PDTC or NAC for 24 h. Medium was used as negative control (data not
shown) and 10% dimethyl sulfoxide (DMSO) as positive control (poco, positive control). The applied amount of the vehicle (veco) was in
accordance to 100 μM QH2. The cell viability of the negative control was set to 100% and the other values (means ± SEM) were
referenced to it. Three independent experiments were performed in triplicate.
10% DMSO Vehicle control 100 μM PDTC 100 μM NAC 1 μM QH2 10 μM QH2 100 μM QH2
% 1.71 148.87 109.44 92.51 120.74 109.68 98.43
±SEM ±0.36 ±15.09 ±22.33 ±21.38 ±13.20 ±15.70 ±16.09C. Schmelzer et al.
J. Clin. Biochem. Nutr.
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agents in the cell culture medium within 4 h, respectively.
Next, we tested the effect of pre-incubation of cells with
10 μM QH2 for 24 h. Thus, as shown in Figure 1A–C, the
LPS-induced responses were significantly decreased to
60.27 ± 9.3%, 48.13 ± 6.93% and 74.36 ± 7.25% for TNF-
α, MIP-1α and RANTES, respectively (Fig. 1A–C). No sig-
nificant effect was found for MCP-1 (Fig. 1D). Pre-
incubation of cells with 10 μM PDTC or 10 μM NAC
decreased TNF-α levels significantly to 47.69 ± 19.07%
and 54.43 ± 17.64%, respectively (Fig. 1A). No significant
effects of PDTC and NAC were found on LPS-induced
secretion levels of other pro-inflammatory mediators.
Inflammation has been related to the pathogenesis of
various diseases, such as atherosclerosis [13]. Monocytes
play an important role in the response to inflammatory
agents, particularly to those derived from gut bacteria and
are able to enter the circulation, such as bacterial endotoxins.
Thus, endotoxins circulate at low concentrations in the
blood of all healthy individuals, but are also increased after
a high-fat meal [14]. However, elevated levels are associated
with an increased risk of atherosclerosis or sepsis [14–16].
For our experiments we used LPS, a compound of gram-
negative bacteria that is also relevant in vivo to trigger a
serious medical inflammatory process in vitro. Finally,
stimulation of monocytes with LPS induces production of
ROS, which in turn activate the transcription factor NFκB
[4, 9] that triggers a large amount of genes encoding for
inflammatory mediators and cytokines [17]. Numerous
studies in monocytes revealed natural occurring antioxidants
as compounds with anti-inflammatory effects [18,  19].
Here we used CoQ10 in order to study its putative anti-
inflammatory effect in the human monocytic cell line THP-
1. For this purpose, we used the reduced form of CoQ10,
QH2, which functions as an antioxidant. To our knowledge,
effects of QH2 on inflammatory markers have not been
investigated so far, because this form of CoQ10 is not
commonly available. Thus, only a few studies were
published using QH2 in vivo. These studies indicate effects
Fig. 1. Effects of pre-treatment of ubiquinol on LPS-induced release of TNF-α (A), MIP-1α (B), RANTES (C) and MCP-1 (D) in
THP-1 cells.
Cells were either pre-treated with 10 μM QH2 or the respective reference substances PDTC or NAC, or medium and vehicle for
24 h. Afterwards, media were removed and cells were treated with LPS (1 μg/ml medium) for 4 h. The resulting concentrations
(pg/μg cellular protein) of TNF-α, MIP-1α, RANTES and MCP-1 of the vehicle controls (+LPS) were set to 100% for QH2-
pretreated cells and the other values were referenced to it. Values from PDTC- and NAC-pretreated cells were related to
medium controls (+LPS) taken as 100%. Statistically significant data (*, p≤0.05; **, p≤0.01; ***, p≤0.001) are means ± SEM
of four (ubiquinol, vehicle) or two (PDTC, NAC, medium) independent experiments performed in duplicate.Reduced Form of Coenzyme Q10 and Inflammation
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of QH2 on safety and bioavailability [20], sperm kinetic
features [21], oxidative imbalance in children with Trisomy
21 [22] and neuroprotection in an animal Parkinson model
[23]. In THP-1 cells, we found that QH2 reduces signifi-
cantly the secretion of the pro-inflammatory agents TNF-α,
MIP-1α, and RANTES in response to LPS. This putative
anti-inflammatory effect of QH2 could be due to its anti-
oxidant property in cell membranes, because LPS-induced
ROS production occurs very closely to the membrane [4].
One important membrane-associated complex that is rele-
vant for generation of ROS in monocytic cells [24] is the
NADPH oxidase. This complex is described to consist of
four proteins, whereas Rac is the most critical component for
a functional NADPH oxidase. Rac is regulated by small
GTP-binding proteins [25]. In this context it was shown that
LPS induced Rac activity and moreover, the NADPH
oxidase-dependent ROS formation [26]. Thus it seems that
LPS directly initiates the NADPH oxidase activity by
downstream signalling pathways. Results from a further
study indicate an up-regulation of the NADPH oxidase
complex through a NFκB-dependent TNF-α activation
process which finally leads to enhanced ROS production
and further NFκB-activation [24]. This in turn might
contribute to sustained releases of pro-inflammatory cyto-
kines and mediators. In this context it was also shown that
the well known antioxidant and radical scavenger NAC
inhibited NFκB-activation via reduction of H2O2 [ 9], an
important reactive oxygen intermediate (ROI) of the
NADPH oxidase pathway. These strong radical scavenging
effects are also described for PDTC [27], which we used as
an additional internal control to describe the putative anti-
inflammatory effects of the reduced form of CoQ10 (QH2), a
compound with strong antioxidant properties. In general it
seems that QH2 mediates stronger anti-inflammatory effects
on the tested pro-inflammatory compounds than PDTC and
NAC, two well known radical scavengers mediating its
anti-inflammatory properties through a diminished NFκB
activation. Thus it seems that the reduced form of CoQ10
(QH2) mediates its anti-inflammatory effects at least in part
through its strong antioxidant properties. However, these
effects may be additionally mediated by gene expression. It
has been shown in skeletal muscle of humans [28], heart of
mice [29], CaCo-2 [30], and HeLa cells [31] that CoQ10
influences the expression of different genes. These hypo-
theses should be tested in future studies. In conclusion, our
results indicate anti-inflammatory effects of the reduced
form of CoQ10 on various proinflammatory cytokines and
chemokines in vitro.
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